GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Active Biotech AB (OSTO:ACTI) » Definitions » Institutional Ownership

Active Biotech AB (OSTO:ACTI) Institutional Ownership : 1.87% (As of Jun. 10, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Active Biotech AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Active Biotech AB's institutional ownership is 1.87%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Active Biotech AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Active Biotech AB's Float Percentage Of Total Shares Outstanding is 0.00%.


Active Biotech AB Institutional Ownership Historical Data

The historical data trend for Active Biotech AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Active Biotech AB Institutional Ownership Chart

Active Biotech AB Historical Data

The historical data trend for Active Biotech AB can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 1.62 1.69 1.69 1.82 1.86 1.88 1.87 1.87 1.87 1.87

Active Biotech AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Active Biotech AB (OSTO:ACTI) Business Description

Traded in Other Exchanges
Address
Scheelevagen 22, Lund, SWE, 223 63
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.

Active Biotech AB (OSTO:ACTI) Headlines

No Headlines